Zhejiang Canaan Technology Limited (SHE:300412)

Market Cap	2.07B -14.2%
Revenue (ttm)	1.11B -20.9%
Net Income	25.36M -32.1%
EPS	0.05 -31.2%
Shares Out	497.76M
PE Ratio	79.72
Forward PE	n/a
Dividend	0.06 (1.39%)
Ex-Dividend Date	Jun 1, 2026

Volume	12,409,330
Open	4.290
Previous Close	4.170
Day's Range	4.090 - 4.290
52-Week Range	4.090 - 6.270
Beta	0.55
Analysts	Buy
Price Target	10.00 (+140.39%)
Earnings Date	Aug 17, 2026

About SHE:300412

Zhejiang Canaan Technology Limited engages in the research and development, production, and sale of pharmaceutical equipment in China and internationally. The company offers preprocessing module, hybrid module, packaging, attachment, granulation, material transport, cleaning, continuous manufacturing, container, freeze drying system, and fluid module products. It also provides EPCMV turnkey, solid dosage, API system, pharmaceutical water, smart packaging, intelligent warehousing and automated logistics, pharmaceutical research and development i...

• Industry: Specialty Industrial Machinery
• Sector: Industrials
• Founded: 2000
• Employees: 1,582
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300412

Financial Performance

In 2025, SHE:300412's revenue was 1.23 billion, a decrease of -10.98% compared to the previous year's 1.38 billion. Earnings were 29.64 million, a decrease of -18.27%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error